During the past decade, Associates in Research conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Associates in Research" #1 sponsor was "Abbott" with 3 trials, followed by "JANSSEN Alzheimer Immunotherapy Research & Development, LLC" with 3 trials sponsored, "Janssen Vaccines & Prevention B.V." with 2 trials sponsored, "Bayer" with 1 trials sponsored and "Bristol-Myers Squibb" with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Associates in Research" #1 collaborator was "Pfizer" with 3 trials as a collaborator, "Daré Bioscience, Inc." with 1 trials as a collaborator, "IQVIA Inc." with 1 trials as a collaborator, "OSTAtistics" with 1 trials as a collaborator and "United States Department of Defense" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Associates in Research" are "HIV Infections" (7 trials), "Alzheimer's Disease" (3 trials), "Botulinum Toxin" (1 trials), "COVID-19 Prevention" (1 trials) and "Candidiasis, Oral" (1 trials). Many other conditions were trialed in "Associates in Research" in a lesser frequency.

Most popular intervention types in "Associates in Research" are "Drug" (14 trials), "Biological" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Efavirenz" (3 trials), "Amprenavir/ritonavir" (2 trials), "Bapineuzumab 0.5 mg/kg" (2 trials) and "Bapineuzumab 1.0 m/kg" (2 trials). Other intervention names were less common.

The vast majority of trials in "Associates in Research" are 14 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Associates in Research". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Associates in Research, 1 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Associates in Research, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".